Dilated cardiomyopathy differential diagnosis: Difference between revisions
Line 14: | Line 14: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical Presentation | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical Presentation | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory Findings | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory Findings | ||
!Electrocardiogram | |||
!Echocardiography | |||
|- | |- | ||
|[[Acute coronary syndromes|Acute Coronary Syndrome]] | |[[Acute coronary syndromes|Acute Coronary Syndrome]] | ||
Line 26: | Line 28: | ||
* [[Nausea and vomiting|Nausea]], vomiting, and [[Perspiration|sweating]] | * [[Nausea and vomiting|Nausea]], vomiting, and [[Perspiration|sweating]] | ||
| | | | ||
* Elevated blood [[troponin]] levels (after 6 hours of attack onset) | * Elevated blood [[troponin]] levels (after 6 hours of attack onset) | ||
* Elevated blood [[CK-MB]] levels | * Elevated blood [[CK-MB]] levels | ||
| | |||
* [[ST segment]] changes | |||
* T wave changes | |||
* Pathological Q waves. | |||
| | |||
|- | |- | ||
|Acute [[Pericarditis]] | |Acute [[Pericarditis]] | ||
Line 42: | Line 50: | ||
* [[Fever]] (for inflammatory causes) | * [[Fever]] (for inflammatory causes) | ||
| | | | ||
*[[Complete blood count|CBC]]: Increased WBCs count | |||
* [[Complete blood count|CBC]]: Increased WBCs count | |||
* Modest increase in [[CK-MB]] | * Modest increase in [[CK-MB]] | ||
* Elevated [[C-reactive protein|CRP]] levels. | * Elevated [[C-reactive protein|CRP]] levels. | ||
| | |||
* Slight ST segment elevation in several leads | |||
* Diffuse T wave inversion | |||
| | |||
|- | |- | ||
|[[Amphetamine]]/[[Cocaine]] | |[[Amphetamine]]/[[Cocaine]] | ||
Line 60: | Line 72: | ||
* Elevated serum CK ([[rhabdomyolysis]]) | * Elevated serum CK ([[rhabdomyolysis]]) | ||
* Impaired electrolytes levels | * Impaired electrolytes levels | ||
| | |||
| | |||
|- | |- | ||
|Arrhythmogenic right ventricular | |Arrhythmogenic right ventricular | ||
Line 74: | Line 88: | ||
* Electrocardiogram | * Electrocardiogram | ||
* Imaging modalities as 2D [[echocardiography]] and MRI. | * Imaging modalities as 2D [[echocardiography]] and MRI. | ||
| | |||
| | |||
|- | |- | ||
|Wet [[Beriberi]] | |Wet [[Beriberi]] | ||
Line 89: | Line 105: | ||
* Reduced urinary thiamine | * Reduced urinary thiamine | ||
* Reduced erythrocyte [[transketolase]] and [[thiamine pyrophosphate]] activities. | * Reduced erythrocyte [[transketolase]] and [[thiamine pyrophosphate]] activities. | ||
| | |||
| | |||
|- | |- | ||
|[[Cardiac tamponade|Cardiac Tamponade]] | |[[Cardiac tamponade|Cardiac Tamponade]] | ||
Line 104: | Line 122: | ||
* Subacute tamponade: Peripheral [[edema]] with gradual progression to the aforementioned clinical picture. | * Subacute tamponade: Peripheral [[edema]] with gradual progression to the aforementioned clinical picture. | ||
| | | | ||
* Increased serum [[Creatine kinase|CK-MB]] and [[troponin]] | * Increased serum [[Creatine kinase|CK-MB]] and [[troponin]] | ||
* Cause-related investigations as serum inflammatory markers, diagnostic pericardiocentesis, and [[Gallium Citrate Ga 67|Gallium]] 67 imaging. | * Cause-related investigations as serum inflammatory markers, diagnostic pericardiocentesis, and [[Gallium Citrate Ga 67|Gallium]] 67 imaging. | ||
| | |||
|Echocardiography to score the [[European society of cardiology|European Society of Cardiology]] (ESC) Working Group on Myocardial and Pericardial Diseases | |||
|- | |- | ||
|[[Hyperthyroidism]] | |[[Hyperthyroidism]] | ||
Line 125: | Line 144: | ||
* [[Thyroid-stimulating hormone|TSH]]: Reduced in 1ry and Elevated in 2ry hyperthyroidism. | * [[Thyroid-stimulating hormone|TSH]]: Reduced in 1ry and Elevated in 2ry hyperthyroidism. | ||
* Thyroid stimulating antibodies: Elevated only in [[Graves' disease|Grave's disease]] | * Thyroid stimulating antibodies: Elevated only in [[Graves' disease|Grave's disease]] | ||
| | |||
| | |||
|- | |- | ||
|[[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]] | |[[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]] | ||
Line 145: | Line 166: | ||
* Electrocardiogram | * Electrocardiogram | ||
* Echocardiography according to ACCF/[[American Heart Association|AHA]] Guideline for the Diagnosis and Treatment of [[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]] | * | ||
| | |||
|Echocardiography according to ACCF/[[American Heart Association|AHA]] Guideline for the Diagnosis and Treatment of [[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]] | |||
|- | |- | ||
|[[Noncompaction cardiomyopathy|Left ventricular noncompaction]] | |[[Noncompaction cardiomyopathy|Left ventricular noncompaction]] | ||
Line 161: | Line 184: | ||
* Echocardiography | * Echocardiography | ||
* Steady-state free precession MRI, showing prominent trabeculations and a non-compacted to compacted (NC/C) myocardium ratio > 2.3 | * Steady-state free precession MRI, showing prominent trabeculations and a non-compacted to compacted (NC/C) myocardium ratio > 2.3 | ||
| | |||
| | |||
|- | |- | ||
|[[Myocarditis]] | |[[Myocarditis]] | ||
Line 183: | Line 208: | ||
* Serological markers such as [[Fas]], [[Fas ligand]], [[interleukin]]-10 or antimyosin autoantibodies | * Serological markers such as [[Fas]], [[Fas ligand]], [[interleukin]]-10 or antimyosin autoantibodies | ||
* Viral antibody titres or autoantibodies (to reach the cause) | * Viral antibody titres or autoantibodies (to reach the cause) | ||
| | |||
| | |||
|- | |- | ||
|[[Restrictive Cardiomyopathies|Restrictive]] Cardiomyopathy | |[[Restrictive Cardiomyopathies|Restrictive]] Cardiomyopathy | ||
Line 195: | Line 222: | ||
*[[Kussmaul's sign|Kussmaul sign]] | *[[Kussmaul's sign|Kussmaul sign]] | ||
*S3 and S4 gallops | *S3 and S4 gallops | ||
| | | | ||
* To verify the cause: measuring [[Iron overload disorder|iron overload]] and [[myocardial biopsy]] | * To verify the cause: measuring [[Iron overload disorder|iron overload]] and [[myocardial biopsy]] | ||
| | |||
* Low [[QRS complex|QRS]] voltages | |||
* Conduction abnormalities. | |||
|Wall and valvular thickening and sparkling myocardium. | |||
|} | |} | ||
Revision as of 14:32, 23 December 2019
Dilated cardiomyopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Dilated cardiomyopathy differential diagnosis On the Web |
American Roentgen Ray Society Images of Dilated cardiomyopathy differential diagnosis |
Risk calculators and risk factors for Dilated cardiomyopathy differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]
Overview
Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction, in particular acute coronary syndrome, other cardiomyopathies (hypertrophic, restrictive, and ARVC/D), myocarditis, pericarditis, and cardiac toxicities.
Differentiating Dilated Cardiomyopathy from other Diseases
Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction, in particular acute coronary syndrome, other cardiomyopathies (hypertrophic, restrictive, and ARVC/D), myocarditis, pericarditis, and cardiac toxicities.[1][2][3][4]
Disorders | Etiology | Clinical Presentation | Laboratory Findings | Electrocardiogram | Echocardiography |
---|---|---|---|---|---|
Acute Coronary Syndrome |
|
|
|||
Acute Pericarditis |
|
|
|
||
Amphetamine/Cocaine
Cardiomyopathy |
|
|
|
||
Arrhythmogenic right ventricular
cardiomyopathy (ARVC/D) |
|
|
Diagnostic criteria are based on:
|
||
Wet Beriberi |
|
|
|
||
Cardiac Tamponade |
|
|
Echocardiography to score the European Society of Cardiology (ESC) Working Group on Myocardial and Pericardial Diseases | ||
Hyperthyroidism |
|
|
|
||
Hypertrophic Cardiomyopathy |
|
The diagnosis is based on
|
Echocardiography according to ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy | ||
Left ventricular noncompaction |
|
|
Diagnosis can be based on:
|
||
Myocarditis |
|
|
|||
Restrictive Cardiomyopathy | Systemic diseases, such as |
|
|
|
Wall and valvular thickening and sparkling myocardium. |
References
- ↑ Amosova EN (1992). "[Differential diagnosis of dilated cardiomyopathy]". Klin Med (Mosk). 70 (3–4): 14–9. PMID 1507837.
- ↑ Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE; et al. (2019). "Dilated cardiomyopathy". Nat Rev Dis Primers. 5 (1): 32. doi:10.1038/s41572-019-0084-1. PMID 31073128.
- ↑ Gurevich MA, Gordienko BV (2003). "[Dilated and ischemic cardiomyopathy: differential diagnosis]". Klin Med (Mosk). 81 (9): 68–71. PMID 14598597.
- ↑ Gurevich MA, Gordienko BV (2003). "[Dilated and ischemic cardiomyopathy: differential diagnosis]". Klin Med (Mosk). 81 (9): 68–71. PMID 14598597.